Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-16 | 2021-09-14+ | ORIC | Chacko Jacob | Pres, CEO, Dir | S - Sale | $25.05 | -8,156 | 2,652 | -75% | -$204.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | S | D | 4,420 | $25.05 | 6,388 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 4,420 shares sold in the price range of $25.00 to $25.22 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-09-15 | S | D | 3,736 | $25.06 | 2,652 | D | — | — | (F3) Represents the weighted average share price of an aggregate total of 3,736 shares sold in the price range of $25.00 to $25.25 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |